Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Luzhu Biotechnology CoHKSE:02480 24 Buyback Yield % is 1.70 as of Aug. 02, 2026, which is 127% above its 10-year median of 0.75. GuruFocus rates HKSE:02480 with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 735 Biotechnology companies, Beijing Luzhu Biotechnology Co ranks better than 95.37% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Luzhu Biotechnology Co Buyback Yield % Chart
HKSE:02480 vs VRTX, REGN, RVMD: Buyback Yield % Comparison
For the Biotechnology subindustry, Beijing Luzhu Biotechnology Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Luzhu Biotechnology Co Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Beijing Luzhu Biotechnology Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Beijing Luzhu Biotechnology Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Luzhu Biotechnology Co (HKSE:02480) has a Buyback Yield % of 1.70 as of Aug. 02, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Beijing Luzhu Biotechnology Co and its competitors. This is 127% above median its historical median of 0.75. According to the industry distribution chart, Beijing Luzhu Biotechnology Co ranks #34 out of 735 companies in the Biotechnology industry, placing it in the top 4.6%.
Is Beijing Luzhu Biotechnology Co's Buyback Yield % too high?
Beijing Luzhu Biotechnology Co's current Buyback Yield % of 1.70 is 127% above median its 10-year median of 0.75. Based on the distribution chart, Beijing Luzhu Biotechnology Co ranks #34 out of 735 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Beijing Luzhu Biotechnology Co has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Beijing Luzhu Biotechnology Co's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Luzhu Biotechnology Co ranks #34 out of 735 companies for Buyback Yield %. This places Beijing Luzhu Biotechnology Co in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Beijing Luzhu Biotechnology Co and its competitors. Beijing Luzhu Biotechnology Co's current Buyback Yield % is 1.70, which is 127% above median its own 10-year median of 0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Luzhu Biotechnology Co stock overvalued right now?
Beijing Luzhu Biotechnology Co (HKSE:02480) has a current Buyback Yield % of 1.70. The current Buyback Yield % is 1.70, which is 127% above median its 10-year median of 0.75. Beijing Luzhu Biotechnology Co's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Beijing Luzhu Biotechnology Co (HKSE:02480), the current Buyback Yield % is 1.70 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beijing Luzhu Biotechnology Co., Ltd. is a biotechnology company committed to developing human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. The Group's product pipeline consisted of three clinical-stage product candidates, including its Core Product, LZ901, and six pre-clinical-stage product candidates.
24GF Score
Get the complete analysis for HKSE:02480
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02480 has been successfully added to your 
